Skip to main content

Co-occurring MDD and Problematic Alcohol Use

  • Chapter
  • First Online:
The Massachusetts General Hospital Guide to Depression

Part of the book series: Current Clinical Psychiatry ((CCPSY))

Abstract

Major depressive disorder (MDD) and problematic alcohol use often co-occur. Unfortunately, the presence of these two conditions is associated with worse short-term and long-term complications. In this chapter, we will review definitions of problematic alcohol use, describe the nature of co-occurring depressive symptoms and problematic alcohol use (i.e., prevalence and consequences), review treatment models for these co-occurring conditions, and provide an example of a protocol examined in several research studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Miller WR, Rollnick S. Motivational interviewing: preparing people to change addictive behavior. New York: Guilford Press; 1991.

    Google Scholar 

  2. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017. Retrieved from https://www.samhsa.gov/data/. Accessed 5/12/2018.

  3. Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, et al. Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiat. 2016;73(1):39–47.

    Article  Google Scholar 

  4. Blanco C, Okuda M, Wright C, Hasin DS, Grant BF, Liu SM, Olfson M. Mental health of college students and their noncollege-attending peers: results from the National Epidemiologic Study on Alcohol and Related Conditions. Arch Gen Psychiatry. 2008;65:1429–37.

    Article  PubMed  Google Scholar 

  5. Cranford JA, Eisenberg D, Serras AM. Substance use behaviors, mental health problems, and use of mental health services in a probability sample of college students. Addict Behav. 2009;34(2):134–45.

    Article  Google Scholar 

  6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington DC 2000.

    Google Scholar 

  7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.

    Book  Google Scholar 

  8. National Institute of Alcohol Abuse and Alcoholism. NIAAA council approves definition of binge drinking. NIAAA Newslett. 2004;3:3.

    Google Scholar 

  9. Kanny D, Liu Y, Brewer RD, Lu H. Binge drinking—United States, 2011. MMWR Suppl. 2013;62(suppl 3):77–80.

    Google Scholar 

  10. Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD. 2010 national and state costs of excessive alcohol consumption. Am J Prev Med. 2015;49(5):e73–9.

    Article  Google Scholar 

  11. Stahre M, Roeber J, Kanny D, Brewer RD, Zhang X. Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Prev Chronic Dis. 2014;11:130293.

    Article  Google Scholar 

  12. Hingson RW, Edwards EM, Heeren T, Rosenbloom D. Age of drinking onset and injuries, motor vehicle crashes, and physical fights after drinking and when not drinking. Alcohol Clin Exp Res. 2009;33(5):783–90.

    Article  PubMed  Google Scholar 

  13. Glasheen C, Pemberton MR, Lipari R, Copello EA, Mattson ME. Binge drinking and the risk of suicidal thoughts, plans, and attempts. Addict Behav. 2015;43:42–9.

    Article  Google Scholar 

  14. Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55(3):159–66.

    Article  Google Scholar 

  15. Jackson KM, Sher KJ, Gotham HJ, Wood PK. Transitioning into and out of large-effect drinking in young adulthood. J Abnorm Psychol. 2001;110(3):378–91.

    Article  CAS  PubMed  Google Scholar 

  16. Jennison KM. The short-term effects and unintended long-term consequences of binge drinking in college: a 10-year follow-up study. Am J Drug Alcohol Abuse. 2004;30(3):659–84.

    Article  Google Scholar 

  17. Ham LS, Hope DA. College students and problematic drinking: a review of the literature. Clin Psychol Rev. 2003;23(5):719–59. Review.

    Article  Google Scholar 

  18. Hingson R, Heeren T, Winter M, Wechsler H. Magnitude of alcohol-related mortality and morbidity among U.S. college students ages 18–24: changes from 1998 to 2001. Annu Rev Public Health. 2005;26:259–79. Review.

    Article  Google Scholar 

  19. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64:830–42.

    Article  Google Scholar 

  20. Currie SR, Patten SB, Williams JV, Wang J, Beck CA, El-Guebaly N, Maxwell C. Comorbidity of major depression with substance use disorders. Can J Psychiatr. 2005;50(10):660–6.

    Article  Google Scholar 

  21. Sullivan LE, Fiellin DA, O’Connor PG. The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med. 2005;118(4):330–41.

    Article  Google Scholar 

  22. Becker SJ, Spirito A, Hernandez L, Barnett NP, Eaton CA, Lewander W, et al. Trajectories of adolescent alcohol use after brief treatment in an emergency department. Drug Alcohol Depend. 2012;125:103–9.

    Article  PubMed  Google Scholar 

  23. Patton R, Lau CH, Blow FC, Ranney ML, Cunningham RM, Walton MA. Prevalence and correlates of depression and drinking behaviors among adolescents and emerging adults in a suburban emergency department. Subst Use Misuse. 2016;51(1):34–40.

    Article  Google Scholar 

  24. Pedrelli P, Borsari B, Lipson SK, Heinze JE, Eisenberg D. Gender differences in the relationships among major depressive disorder, heavy alcohol use, and mental health treatment engagement among college students. J Stud Alcohol Drugs. 2016;77(4):620–8.

    Article  PubMed  Google Scholar 

  25. Dixit AR, Crum RM. Prospective study of depression and the risk of heavy alcohol use in women. Am J Psychiatry. 2000;157(5):751–8.

    Article  CAS  Google Scholar 

  26. Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman AT, Penninx BW. Alcohol use disorders and the course of depressive and anxiety disorders. Br J Psychiatry. 2012;200(6):476–84.

    Article  Google Scholar 

  27. Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello LR, Michael J. The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry. 1998;55(3):259–65.

    Article  CAS  Google Scholar 

  28. Suter M, Strik W, Moggi F. Depressive symptoms as a predictor of alcohol relapse after residential treatment programs for alcohol use disorder. J Subst Abus Treat. 2011;41(3):225–32.

    Article  Google Scholar 

  29. Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Beekman AT, Penninx BW. Predictors of the 2-year recurrence and persistence of alcohol dependence. Addiction. 2012;107(9):1639–40.

    Article  Google Scholar 

  30. Camatta CD, Nagoshi CT. Stress, depression, irrational beliefs, and alcohol use and problems in a college student sample. Alcohol Clin Exp Res. 1995;19(1):142–6.

    Article  CAS  Google Scholar 

  31. Marmorstein NR. Longitudinal associations between depressive symptoms and alcohol problems: the influence of comorbid delinquent behavior. Addict Behav. 2010;35(6):564–71.

    Article  PubMed  Google Scholar 

  32. Kenney S, Jones RN, Barnett NP. Gender differences in the effect of depressive symptoms on prospective alcohol expectancies, coping motives, and alcohol outcomes in the first year of college. J Youth Adolesc. 2015;44(10):1884–97.

    Article  PubMed  Google Scholar 

  33. Pedrelli P, Collado A, Shapero BG, Brill C, MacPherson L. Different pathways explain alcohol-related problems in female and male college students. J Am Coll Heal. 2016;64(7):535–44.

    Article  Google Scholar 

  34. Bravo AJ, Pearson MR. In the process of drinking to cope among college students: an examination of specific vs. global coping motives for depression and anxiety symptoms. Addict Behav. 2017;73:94–8.

    Article  Google Scholar 

  35. Marlatt GA, Gordon JR, editors. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford Press; 1985.

    Google Scholar 

  36. National Institute of Alcohol Abuse and Alcoholism, NIH Publication No. 13–5329 Published 2003, Revised 2014.

    Google Scholar 

  37. Capron DW, Bauer BW, Madson MB, Schmidt NB. Treatment seeking among college students with comorbid hazardous drinking and elevated mood/anxiety symptoms. Subst Use Misuse. 2017;27:1–10.

    Google Scholar 

  38. Babor TF, de la Fuente JR, Saunders J, Grant M. AUDIT: the alcohol use disorders identification test. Guidelines for use in primary health care. Geneva: World Health Organization; 1992.

    Google Scholar 

  39. Sauders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption – II. Addiction. 1993;88(6):791–804.

    Article  Google Scholar 

  40. Babor T, Higgins-Biddle J, Higgins P, Gassman R, Gould B. Training medical providers to conduct alcohol screening and brief interventions. Subst Abus. 2004;25:17–26.

    Article  PubMed  Google Scholar 

  41. Babor T, McRee B, Kassebaum P, Grimaldi P, Ahmed K, Bray J. Screening, brief intervention, and referral to treatment (SBIRT). Subst Abus. 2007;28(3):7–30.

    Article  Google Scholar 

  42. Barata IA, Shandro JR, Montgomery M, Polansky R, Sachs CJ, Duber HC, et al. Effectiveness of SBIRT for alcohol use disorders in the emergency department: a systematic review. West J Emerg Med. 2017;18(6):1143–52.

    Article  PubMed  Google Scholar 

  43. Taggart IH, Ranney ML, Howland J, Mello MJ. A systematic review of emergency department interventions for college drinkers. J Emerg Med. 2013;45(6):962–8.

    Article  Google Scholar 

  44. Singh M, Gmyrek A, Hernandez A, Damon D, Hayashi S. Sustaining screening, brief intervention and referral to treatment (SBIRT) services in health-care settings. Addiction. 2017;112(Suppl 2):92–100.

    Article  Google Scholar 

  45. Clark DB, Bukstein OG. Psychopathology in adolescent alcohol abuse and dependence. Alcohol Health Res World. 1998;22(2):117–21. 126. Review.

    CAS  Google Scholar 

  46. Drake RE, Mueser KT, Clark RE, Wallach MA. The course, treatment, and outcome of substance disorder in persons with severe mental illness. Am J Orthopsychiatry. 1996;66(1):42–51.

    Article  CAS  Google Scholar 

  47. Cornelius JR, Bukstein OG, Salloum IM, Kelly TM, Wood DS, Duncan B. Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation. J Child Adolesc Psychopharmacol. 2004;14(1):33–8.

    Article  Google Scholar 

  48. Timko C, Dixon K, Moos RH. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems. Ment Health Serv Res. 2005;7(4):229–42.

    Article  Google Scholar 

  49. Beck AT. Depression: causes and treatment. Philadelphia: University of Pennsylvania Press; 1967.

    Google Scholar 

  50. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000;68(4):615–23.

    Article  CAS  PubMed  Google Scholar 

  51. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26(1):17–31.

    Article  Google Scholar 

  52. Dobson KS. Evaluation of the adequacy of cognitive/behavioural theories for understanding depression in women: a commentary. Can Psychol J. 1989;30(1):56–8.

    Article  Google Scholar 

  53. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord. 1998;49(1):59–72.

    Article  CAS  Google Scholar 

  54. Miller BE, Miller MN, Verhegge R, Linville HH, Pumariega AJ. Alcohol misuse among college athletes: self-medication for psychiatric symptoms? J Drug Educ. 2002;32(1):41–52.

    Article  CAS  Google Scholar 

  55. Dimeff LA, Baer JS, Kivlaha DR, Marlatt GA. Brief alcohol screening and intervention for college students (BASICS): a harm reduction approach. New York: Guilford Press; 1999.

    Google Scholar 

  56. Larimer ME, Cronce JM. Identification, prevention and treatment: a review of individual-focused strategies to reduce problematic alcohol consumption by college students. J Stud Alcohol Suppl. 2002;14:148–63.

    Article  Google Scholar 

  57. Larimer ME, Cronce JM. Identification, prevention, and treatment revisited: individual-focused college drinking prevention strategies 1999–2006. Addict Behav. 2007;32(11):2439–68.

    Article  Google Scholar 

  58. Baker AL, Kavanagh DJ, Kay-Lambkin FJ, Hunt SA, Lewin TJ, Carr VJ, Connolly J. Randomized controlled trial of cognitive behavioural therapy for coexisting depression and alcohol problems: short-term outcome. Addiction. 2010;105(1):87–99.

    Article  Google Scholar 

  59. Baker AL, Kavanagh DJ, Kay-Lambkin FJ, Hunt SA, Lewin TJ, Carr VJ, McElduff P. Randomized controlled trial of MICBT for co-existing alcohol misuse and depression: outcomes to 36-months. J Subst Abus Treat. 2014;46(3):281–90.

    Article  Google Scholar 

  60. Kay-Lambkin FJ, Baker A, Lewin TJ. Computer-based psychological treatment for comorbid depression and substance use problems: a randomised controlled trial of clinical efficacy. Addiction. 2009;104:378–88.

    Article  Google Scholar 

  61. Deady M, Mills KL, Teesson M, Kay-Lambkin F. An online intervention for co-occurring depression and problematic alcohol use in young people: primary outcomes from a randomized controlled trial. J Med Internet Res. 2016;18(3):e71.

    Article  PubMed  Google Scholar 

  62. Satre DD, Leibowitz A, Sterling SA, Lu Y, Travis A, Weisner C. A randomized clinical trial of Motivational Interviewing to reduce alcohol and drug use among patients with depression. J Consult Clin Psychol. 2016;84(7):571–9.

    Article  PubMed  Google Scholar 

  63. Riper H, Andersson G, Hunter SB, de Wit J, Berking M, Cuijpers P. Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis. Addiction. 2014;109:394–406.

    Article  PubMed  Google Scholar 

  64. McCarter KL, Halpin SA, Baker AL, Kay-Lambkin FJ, Lewin TJ, Thornton LK, et al. Associations between personality disorder characteristics and treatment outcomes in people with co-occurring alcohol misuse and depression. BMC Psychiatry. 2016;16:210.

    Article  PubMed  Google Scholar 

  65. Helton SG, Lohoff FW. Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders. Psychiatry Res. 2015;230:121–9.

    Article  CAS  Google Scholar 

  66. Gianoli MO, Petrakis IL. Pharmacotherapy for comorbid depression and alcohol dependence. Curr Psychiatr Ther. 2013;12(1):24–33.

    Google Scholar 

  67. DeVido JJ, Weiss RD. Treatment of the depressed alcoholic patient. Curr Psychiatry Rep. 2012;14(6):610–8.

    Article  PubMed  Google Scholar 

  68. Iovieno N, Tedeschini E, Bentley KH, Evins AE, Papakostas GI. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry. 2011;72(8):1144–51.

    Article  Google Scholar 

  69. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA. 2004;291(15):1887–96.

    Article  CAS  Google Scholar 

  70. Greenfield BL, Venner KL, Kelly JF, Slaymaker V, Bryan AD. The impact of depression on abstinence self-efficacy and substance use outcomes among emerging adults in residential treatment. Psychol Addict Behav. 2012;26(2):246–54.

    Article  PubMed  Google Scholar 

  71. Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, et al. A double blind, placebo-controlled trial that combines sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry. 2010;167(6):668–57.

    Article  PubMed  Google Scholar 

  72. Grant BF, Stinson FS, Hasin DS, et al. Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:1226–33.

    Article  Google Scholar 

  73. Reis RK, Yuodelis-Flores C, Comtois KA, et al. Substance-induced suicidal admissions to an acute psychiatric service: characteristics and outcomes. J Subst Abus Treat. 2008;34:72–9.

    Article  Google Scholar 

  74. Shade Program. Retrieved at www.shadetreatment.com.au/ . Accessed 4 May 2018.

  75. Kay-Lambkin F, Baker A, Bucci S. Treatment manual for the SHADE project (self-help for alcohol/other drug use and depression). Callahan: University of Newcastle; 2002.

    Google Scholar 

  76. The National Institute on Alcohol and Alcoholism (NIAAA). Rethinking drinking. NIH Publication No. 15-3770. 2016. Revised May 2016.

    Google Scholar 

  77. Hester RK, Miller WR. Handbook of alcoholism treatment approaches. 2nd ed. Boston: Allyn and Bacon; 1995.

    Google Scholar 

  78. McLennan JD, Shaw E, Shema SJ, Gardner WP, Pope SK, Kelleher KJ. Adolescents’ insight in heavy drinking. J Adolesc Health. 1998;22(5):409–16.

    Article  CAS  Google Scholar 

  79. National Institute of Alcohol Abuse and Alcoholism. Recommended alcohol questions. Retrieved from https://www.niaaa.nih.gov/research/guidelines-and-resources/recommended-alcohol-questions. Accessed 5/12/2018.

  80. Miller WR, Leckman AL, Delaney HD, Tinkom M. Long-term follow-up of behavioral self-control training. J Stud Alcohol. 1992;53(3):249–61.

    Article  CAS  Google Scholar 

  81. Walters G. Behavioral self-control training for problem drinkers: a meta-analysis of randomized control studies. Behav Ther. 2000;31(1):135–49.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paola Pedrelli .

Editor information

Editors and Affiliations

FAQs: Common Questions and Answers

FAQs: Common Questions and Answers

  • Q1. What is the best approach with a patient reporting drinking over the recommended guidelines?

  • A1. Evidence suggests that many patients seeking treatment for depression may also engage in heavy alcohol use. Clinicians should therefore systematically inquire about alcohol consumption during intake and throughout the course of treatment. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) recommends brief intervention with individuals with “at risk” drinking or “heavy drinking,” defined as drinking 5 drinks on any day or 14 per week for men and drinking more than 3 drinks on any day and 7 per week for women [76]. Patients may not be aware that their drinking is considered “at risk,” and education on NIAAA-recommended guidelines and on the risk associated with higher alcohol use is an important first step of treatment. Clinicians should carefully review all possible consequences that patients may have already experienced due to their alcohol consumption, including health-related problems, relationship problems (i.e., arguments with friends or significant others), legal problems (e.g., DUI), and employment problems (e.g., missing days at work).

  • Given the low insight often associated with problematic drinking, clinicians may use MI techniques [1], which follow five general principles: express empathy through reflective listening, develop discrepancy between clients’ goals or values and their current behavior, avoid argument and direct confrontation, adjust to client resistance rather than opposing it directly, and support self-efficacy and optimism. Clinicians may also adopt communication techniques consistent with the spirit of MI, such as reflective statements, affirmation, evocation, and use statements that highlight discrepancies between the patient current behaviors and his/her goals. These principles are characterized by the brief intervention structure of FRAMES which refers to the use of Feedback, Responsibility for change lying with the individual, Advice-giving, providing a Menu of change options, Empathic counseling style, and the enhancement of Self-efficacy [77]. Thus, clinicians may focus on enhancing discrepancies between alcohol use and personal goals and collaboratively identify drinking goals that fall within the recommended guidelines and may be consistent with patients’ goals. Progressively, depression and alcohol use would be addressed in conjunction, highlighting their association and strengthening the patient’s motivation to not engage in heavy drinking.

  • Q2. What is the best setting for treating co-occurring depression and alcohol misuse?

  • A2. One important clinical consideration to be mindful of when treating patients with co-occurring MDD and problematic alcohol use is that these patients often have low insight into the problems associated with their drinking behavior [78] and thus may have low motivation to change. Often their goal for treatment is to only reduce their alcohol consumption. Hence, patients with problematic alcohol use may not be willing to attend specialty clinics serving patients with co-occurring MDD and SUD because they are not interested in abstinence (often required in these programs) and because they may not want to interface with patients with severe addictive behaviors with whom they may not identify. Patients with problematic alcohol use may be more open to receiving treatment in general outpatient psychiatry clinics focusing on depression and related conditions (e.g., anxiety). Moreover, whereas patients with SUD often attend more intensive outpatient (e.g., intensive outpatient, partial hospitalization) programs, once-weekly treatment sessions may be an appropriate level of care for individuals with MDD and co-occurring problematic alcohol use (i.e., milder forms of AUD) [62, 63]. As such, it has been argued that treating problematic alcohol use among those with MDD may be an ideal strategy to address this high-risk behavior because these patients do not seek treatment for their alcohol use but are interested in treatment for MDD.

  • Q3. When is it better to adopt a sequential versus integrated treatment approach?

  • A3. Research has generally shown that integrated treatment is associated with better outcomes for patients with co-occurring depression and alcohol problems. However, if clinicians do not have experience in treating problematic drinking and/or the treatment setting lacks necessary resources, it is advisable to refer the patient for a short course of MI by a clinician who is well versed in this method. As noted above, neglecting to address the problematic alcohol use may also prevent improvement of mood symptoms.

  • Q4. What is the best way to assess for problematic alcohol use?

  • A4. The Task Force on Recommended Alcohol Questions, a task force of NIAAA’s Council, developed minimum sets of downward compatible alcohol consumption questions, and they recommended sets of 3, 4, 5, and 6 items presented here which resulted from the work of that task force. They recommend asking a minimum of three questions including frequency of drinking in the past year (e.g., “During the last 12 months, how often did you usually have any kind of drink containing alcohol?”), number of drinks consumed on a typical drinking day in the past 12 months (e.g., “During the last 12 months, how many alcoholic drinks did you have on a typical day when you drank alcohol?”), and frequency of heavy drinking in the past 12 months (e.g., “During the last 12 months, how often did you have five or more drinks [males] or four or more drinks [females] containing any kind of alcohol in within a 2-hour period?”). The four-item set adds a question about the maximum number of drinks consumed in a 24-h period in the past year (e.g., “During your lifetime, what is the maximum number of drinks containing alcohol that you drank within a 24-hour period?”), and the five-item set adds a question about maximum drinks in a 24 h period in the respondent’s lifetime (e.g., “During the last 12 months what is the maximum number of drinks containing alcohol that you drank within a 24-hour period?”). The six-item set adds a question, immediately following the item about maximum drinks in a 24-h period in the past 12 months, which asks about the frequency of consuming this maximum number of drinks in the past 12 months (e.g., “During the last 12 months, how often did you drink this largest number of drinks?”) [79].

  • Similarly, the Alcohol Use Disorders Identification Test (AUDIT) [38] is a self-report screening tool extensively used to identify individuals with problematic drinking. The AUDIT is a ten-item screening questionnaire with three questions inquiring about amount and frequency of drinking, three questions on alcohol dependence, and four on problems caused by alcohol. All the items are scored using a Likert scale from 1 to 5, and total scores range from 0 to 40. Norms have been developed for this instrument, but overall the authors advise to provide alcohol education in the case of scores between 0 and 7, simple advice with scores between 8 and 15, and simple advice plus brief counseling and continued monitoring in the case of scores between 16 and 19 [38].

  • Q5. What is the difference between having treatment goals of abstinence and moderate drinking?

  • A5. In the presence of heavy episodic drinking, the common approach is a harm reduction strategy in which the goal consists of engaging in alcohol consumption within recommended guidelines. Most individuals with problematic alcohol use initially are not open to abstain from alcohol use, making alcohol reduction the most feasible goal. Some patients may be unable to reduce drinking even though they do not meet criteria for AUD because of inability to control themselves. In those cases, it is recommended clinicians review the pros and cons of abstinence with the patient. There is debate as to whether a harm reduction strategy would be appropriate for severe AUD, but that is outside the scope of the current chapter focused on MDD and less severe forms of AUD [80, 81].

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pedrelli, P., Bentley, K.H. (2019). Co-occurring MDD and Problematic Alcohol Use. In: Shapero, B., Mischoulon, D., Cusin, C. (eds) The Massachusetts General Hospital Guide to Depression. Current Clinical Psychiatry. Humana Press, Cham. https://doi.org/10.1007/978-3-319-97241-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-97241-1_2

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-97240-4

  • Online ISBN: 978-3-319-97241-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics